Skip to main content
Clinical Trials/NCT01768871
NCT01768871
Terminated
N/A

Prospective, Long-Term, Multi-Center Study on the Efficacy of the VEGA System® for Total Knee Arthroplasty.

Aesculap Implant Systems3 sites in 1 country7 target enrollmentJanuary 2013

Overview

Phase
N/A
Intervention
Not specified
Conditions
Patients With Total Knee Arthroplasty Using the VEGA System
Sponsor
Aesculap Implant Systems
Enrollment
7
Locations
3
Primary Endpoint
WOMAC
Status
Terminated
Last Updated
7 years ago

Overview

Brief Summary

The primary objective of this study is to evaluate the function of the knee after a total knee replacement with the VEGA system®.

Detailed Description

To evaluate patients after total knee arthroplasty in terms of function for five years.

Registry
clinicaltrials.gov
Start Date
January 2013
End Date
July 2015
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Aesculap Implant Systems
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • willing to sign the informed consent.
  • Patient has intact collateral ligaments.

Exclusion Criteria

  • Inflammatory arthritis
  • Patients that have had a high tibial osteotomy or femoral osteotomy
  • Patients with neuromuscular or neurosensory deficiency which would make it difficult to assess the device performance.

Outcomes

Primary Outcomes

WOMAC

Time Frame: Two years

WOMAC function score 2 years post arthroplasty

Secondary Outcomes

  • Health related quality of life(Two years)

Study Sites (3)

Loading locations...

Similar Trials